首页 > 最新文献

Forschende Komplementarmedizin最新文献

英文 中文
[Does salt prolong your life?]. 盐能延年益寿吗?
Q Medicine Pub Date : 2007-06-01
Karl-Ludwig Resch
{"title":"[Does salt prolong your life?].","authors":"Karl-Ludwig Resch","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 3","pages":"184-5"},"PeriodicalIF":0.0,"publicationDate":"2007-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26906259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is black cohosh a hepatotoxic medicinal herb? 黑升麻是一种肝毒性草药吗?
Q Medicine Pub Date : 2007-04-01 Epub Date: 2007-04-23 DOI: 10.1159/000101352
Luigi Gori, Fabio Firenzuoli
Recently, the European Medicines Agency (EMEA) and the Committee on Herbal Medicinal Products (HMPC) have released a public statement to draw the attention of European health authorities to 42 cases (34 directly reported from European national competent authorities and 8 published) of suspected hepatotoxic reactions to Cimicifugae racemosae rhizoma (black cohosh, root) in patients, probably all of them women, who were treated for menopause-related disorders. Following a review of all data available, this statement assumes a connection between herbal medicinal products that contain Cimicifugae racemosae rhizoma and human hepatotoxic adverse reactions. Nevertheless, this highly authoritative review of such an impressive number of cases concludes in its summary that ‘Overall, all discussed cases of literature and pharmacovigilance reports are poorly documented,’ and only ‘two can be considered as possible’ and ‘two can be classified as probable’ [1, p 9]: (1) In case 28, according to the numeration in the EMEA statement, RUCAM score 4, the only case directly collected from European national competent authorities, the adverse reaction was considered possible, but information on differential diagnostic assessment was not available. The patient consumed 80 mg of an unknown extract daily and for an unknown period. (2) In another case report [2] (RUCAM score 3) the patient was a 54-year-old woman suffering from hypothyroidism, fibromyalgia, osteoarthritis and depression. She had taken 1,000 mg black cohosh (unclear, if a type of extract or crude drug) daily for several months. The patient was on fluoxetine, propoxyphene and paracetamol (a well known hepatotoxic substance) concomitantly and used to drink 2 glasses of wine in the evenings. The statement claims ‘that since there is no further information on the herbal preparation, the case report is not of great relevance in the assessment of cimicifuga-related hepatotoxicity’ [1]. (3) A 57-year-old multimorbid Afro-American woman [3] (RUCAM score 7) with a history of polymyositis had developed an autoimmune hepatitis about 3 weeks after the first intake of Cimicifugae racemosae rhizoma (brand and dose unknown; no information if it was a combination product). After discontinuation of Cimicifugae racemosae rhizoma intake and starting a therapy with steroids and azathioprine, the patient recovered. Here, autoimmune hepatitis may as well have been a manifestation of a multisystem autoimmune disease. According to the draft recommendations of the Scientific Advisory Panel Subgroups on Hepatotoxicity, the case could be classified as idiosyncratic liver necrosis. Inititally, the causal relationship to black cohosh in this case was assessed ‘unclassifiable’, as information concerning the reaction was considered incomplete and inconsistent, and the follow-up publication includes more (although to some extent still inconsistent) information about the therapy [1]). (4) In another well-documented case [4] (RUCAM score
{"title":"Is black cohosh a hepatotoxic medicinal herb?","authors":"Luigi Gori, Fabio Firenzuoli","doi":"10.1159/000101352","DOIUrl":"https://doi.org/10.1159/000101352","url":null,"abstract":"Recently, the European Medicines Agency (EMEA) and the Committee on Herbal Medicinal Products (HMPC) have released a public statement to draw the attention of European health authorities to 42 cases (34 directly reported from European national competent authorities and 8 published) of suspected hepatotoxic reactions to Cimicifugae racemosae rhizoma (black cohosh, root) in patients, probably all of them women, who were treated for menopause-related disorders. Following a review of all data available, this statement assumes a connection between herbal medicinal products that contain Cimicifugae racemosae rhizoma and human hepatotoxic adverse reactions. Nevertheless, this highly authoritative review of such an impressive number of cases concludes in its summary that ‘Overall, all discussed cases of literature and pharmacovigilance reports are poorly documented,’ and only ‘two can be considered as possible’ and ‘two can be classified as probable’ [1, p 9]: (1) In case 28, according to the numeration in the EMEA statement, RUCAM score 4, the only case directly collected from European national competent authorities, the adverse reaction was considered possible, but information on differential diagnostic assessment was not available. The patient consumed 80 mg of an unknown extract daily and for an unknown period. (2) In another case report [2] (RUCAM score 3) the patient was a 54-year-old woman suffering from hypothyroidism, fibromyalgia, osteoarthritis and depression. She had taken 1,000 mg black cohosh (unclear, if a type of extract or crude drug) daily for several months. The patient was on fluoxetine, propoxyphene and paracetamol (a well known hepatotoxic substance) concomitantly and used to drink 2 glasses of wine in the evenings. The statement claims ‘that since there is no further information on the herbal preparation, the case report is not of great relevance in the assessment of cimicifuga-related hepatotoxicity’ [1]. (3) A 57-year-old multimorbid Afro-American woman [3] (RUCAM score 7) with a history of polymyositis had developed an autoimmune hepatitis about 3 weeks after the first intake of Cimicifugae racemosae rhizoma (brand and dose unknown; no information if it was a combination product). After discontinuation of Cimicifugae racemosae rhizoma intake and starting a therapy with steroids and azathioprine, the patient recovered. Here, autoimmune hepatitis may as well have been a manifestation of a multisystem autoimmune disease. According to the draft recommendations of the Scientific Advisory Panel Subgroups on Hepatotoxicity, the case could be classified as idiosyncratic liver necrosis. Inititally, the causal relationship to black cohosh in this case was assessed ‘unclassifiable’, as information concerning the reaction was considered incomplete and inconsistent, and the follow-up publication includes more (although to some extent still inconsistent) information about the therapy [1]). (4) In another well-documented case [4] (RUCAM score ","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 2","pages":"109-10"},"PeriodicalIF":0.0,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000101352","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26691182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
[Health promotion and prevention in medicine--empowering rather than prescribing]. [医学中的健康促进和预防——授权而不是开处方]。
Q Medicine Pub Date : 2007-04-01 DOI: 10.1159/000100934
Dieter Melchart
In der Beratung von Gesunden und in der Behandlung von chronisch Kranken ist die Förderung ihrer Gesundheit meist das wichtigste Ordnungsund Therapieziel. Dabei steht die Verbesserung der individuellen Gesundheitskompetenz, der Lebensqualität, des persönlichen Wohlbefindens und der Genusssowie Leistungsfähigkeit des Einzelnen im Vordergrund. In den westlichen, überwiegend konservativen und sozialliberalen Gesellschaften zeigt sich ein Trend zu mehr Emanzipation und Selbstbestimmung in Gesundheitsund Krankheitsfragen: Der früher passive Konsument oder uninformierte Patient wird zunehmend zum aktiven, mitbestimmenden Partner. Forderungen nach informationeller Selbstbestimmung, Zweitmeinungen bei wichtigen medizinischen Entscheidungen und Berücksichtigung von Vorlieben für bestimmte Interventionen (z.B. Naturheilverfahren) sind immer häufiger anzutreffen. Die begrenzten finanziellen Ressourcen des Gesundheitssystems und die wachsende Einsicht, dass es nicht sinnvoll ist, einen Großteil davon in die Versorgung von Folgeschäden und Endzuständen chronischer Erkrankungen zu investieren, werden künftig dazu zwingen, stärker in die Prävention und Gesundheitsförderung zu investieren als bislang. Folglich rücken Themen wie Prophylaxe, Selbstbehandlung und Förderung von Selbstkompetenz in den Vordergrund der Reformdiskussionen. Auch die abnehmende Zahl von Erwerbstätigen, die für immer mehr Rentnerinnen und Rentner die Altersruhegelder erwirtschaften müssen, hat sich für diese Aufgabe am Arbeitsplatz gesund zu erhalten. Damit wird Gesundheitsförderung zu einer gesamtgesellschaftlichen Aufgabe, die auf die Unterstützung der Gesundheitsmündigkeit aller Bürger abzielt. Sie soll zu einem gesundheitsfördernden Lebensstil im Alltag befähigen und als bevorzugtes Lebensweisenkonzept propagiert werden. Diese Befähigung des Gesunden und Kranken ist eine gegenwärtige und anhaltende Aufgabe, bei der einer klassischen Naturheilkunde vielfältige Bedeutung zukommt [1, 2]. Neben den gesellschaftlichen Veränderungen fördern aber auch wissenschaftliche und technologische Entwicklungen eine in Richtung Gesundheit und Selbstregulation orientierte, salutogene Medizin. Hierzu zählt die Erkenntnis, dass die Wirklichkeit von Leben (also von Gesundheit und Krankheit) aus verschiedenen wissenschaftlichen Paradigmen zu betrachten und zu analysieren ist. Eine umfassende und kontextbezogene wissenschaftliche Betrachtung des Menschen bezieht – neben dem biomedizinischen körperlichen Modell – psychische Prozesse, individuelles Verhalten und Gewohnheiten, Familie sowie Freunde als biographisches Modell mit ein. Da Personen in Gemeinschaften leben, ist auch ihre Rolle in der Gesellschaft, am Arbeitsplatz und im Gemeinwesen ein wichtiger Aspekt, der – nach Göpel [3] – als ethnographisches Modell die Verhältnisse der Menschen beschreibt. Schließlich unterscheidet Göpel noch das ökologische Modell, das den Lebensraum, die Lokalitäten des Menschen, analysiert. Eine solche pluralistische wissens
{"title":"[Health promotion and prevention in medicine--empowering rather than prescribing].","authors":"Dieter Melchart","doi":"10.1159/000100934","DOIUrl":"https://doi.org/10.1159/000100934","url":null,"abstract":"In der Beratung von Gesunden und in der Behandlung von chronisch Kranken ist die Förderung ihrer Gesundheit meist das wichtigste Ordnungsund Therapieziel. Dabei steht die Verbesserung der individuellen Gesundheitskompetenz, der Lebensqualität, des persönlichen Wohlbefindens und der Genusssowie Leistungsfähigkeit des Einzelnen im Vordergrund. In den westlichen, überwiegend konservativen und sozialliberalen Gesellschaften zeigt sich ein Trend zu mehr Emanzipation und Selbstbestimmung in Gesundheitsund Krankheitsfragen: Der früher passive Konsument oder uninformierte Patient wird zunehmend zum aktiven, mitbestimmenden Partner. Forderungen nach informationeller Selbstbestimmung, Zweitmeinungen bei wichtigen medizinischen Entscheidungen und Berücksichtigung von Vorlieben für bestimmte Interventionen (z.B. Naturheilverfahren) sind immer häufiger anzutreffen. Die begrenzten finanziellen Ressourcen des Gesundheitssystems und die wachsende Einsicht, dass es nicht sinnvoll ist, einen Großteil davon in die Versorgung von Folgeschäden und Endzuständen chronischer Erkrankungen zu investieren, werden künftig dazu zwingen, stärker in die Prävention und Gesundheitsförderung zu investieren als bislang. Folglich rücken Themen wie Prophylaxe, Selbstbehandlung und Förderung von Selbstkompetenz in den Vordergrund der Reformdiskussionen. Auch die abnehmende Zahl von Erwerbstätigen, die für immer mehr Rentnerinnen und Rentner die Altersruhegelder erwirtschaften müssen, hat sich für diese Aufgabe am Arbeitsplatz gesund zu erhalten. Damit wird Gesundheitsförderung zu einer gesamtgesellschaftlichen Aufgabe, die auf die Unterstützung der Gesundheitsmündigkeit aller Bürger abzielt. Sie soll zu einem gesundheitsfördernden Lebensstil im Alltag befähigen und als bevorzugtes Lebensweisenkonzept propagiert werden. Diese Befähigung des Gesunden und Kranken ist eine gegenwärtige und anhaltende Aufgabe, bei der einer klassischen Naturheilkunde vielfältige Bedeutung zukommt [1, 2]. Neben den gesellschaftlichen Veränderungen fördern aber auch wissenschaftliche und technologische Entwicklungen eine in Richtung Gesundheit und Selbstregulation orientierte, salutogene Medizin. Hierzu zählt die Erkenntnis, dass die Wirklichkeit von Leben (also von Gesundheit und Krankheit) aus verschiedenen wissenschaftlichen Paradigmen zu betrachten und zu analysieren ist. Eine umfassende und kontextbezogene wissenschaftliche Betrachtung des Menschen bezieht – neben dem biomedizinischen körperlichen Modell – psychische Prozesse, individuelles Verhalten und Gewohnheiten, Familie sowie Freunde als biographisches Modell mit ein. Da Personen in Gemeinschaften leben, ist auch ihre Rolle in der Gesellschaft, am Arbeitsplatz und im Gemeinwesen ein wichtiger Aspekt, der – nach Göpel [3] – als ethnographisches Modell die Verhältnisse der Menschen beschreibt. Schließlich unterscheidet Göpel noch das ökologische Modell, das den Lebensraum, die Lokalitäten des Menschen, analysiert. Eine solche pluralistische wissens","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 2","pages":"68-9"},"PeriodicalIF":0.0,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000100934","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26767211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Pilot study of breathing therapy in groups for patients with bronchial asthma]. [支气管哮喘患者分组呼吸治疗的初步研究]。
Q Medicine Pub Date : 2007-04-01 Epub Date: 2007-04-23 DOI: 10.1159/000100378
Karoline von Steinaecker, Justus Welke, Malte Bühring, Rainer Stange

Background: The present study examines the efficacy of breathing and body therapy (according to the organization of breathing therapists, BVA) on bronchial asthma. This psychophysical therapy procedure has never before been studied for its efficacy on asthma, much in contrast to breathing exercises, which have been extensively examined.

Patients and methods: This uncontrolled observational study is of preliminary character. It examines the influence of psychophysical breathing and body exercises practiced in short-term intervention groups on quality of life (SF-36) as well as subjective discomfort (discomfort diary) in patients with bronchial asthma. As there are no prior studies on the breathing and body therapy (BVA) method, it was hypothesized, based on experience, that it would improve ventilation, lower anxiety, and perhaps even allow for a reduction of medication.

Results: An anti-obstructive effect could not be addressed here, as the study only included patients who were free of clinically relevant obstructions through conventional treatment. However, a tendency for an anxiety-relieving effect could be observed in the SF-36. Subjective reports of respiratory discomfort, obtained through assessment of the patients' diaries, did not show any tendencies or even significant changes over the course of the therapy.

Conclusion: The suggested anxiety-relieving effect of breathing therapy should be examined in future studies with more patients and stricter inclusion criteria.

背景:本研究探讨呼吸和身体疗法(根据呼吸治疗师组织,BVA)对支气管哮喘的疗效。这种心理物理治疗方法对哮喘的疗效从未进行过研究,这与呼吸练习形成了很大的对比,而呼吸练习已经得到了广泛的研究。患者和方法:本研究为非对照观察性初步研究。它检查了短期干预组中心理物理呼吸和身体锻炼对支气管哮喘患者生活质量(SF-36)以及主观不适(不适日记)的影响。由于之前没有关于呼吸和身体治疗(BVA)方法的研究,根据经验,人们假设它会改善通气,降低焦虑,甚至可能减少药物治疗。结果:由于本研究仅纳入了通过常规治疗无临床相关梗阻的患者,因此不能解决抗梗阻作用。然而,在SF-36中可以观察到缓解焦虑效果的趋势。通过对患者日记的评估获得的呼吸不适的主观报告在治疗过程中没有显示出任何趋势,甚至没有显着的变化。结论:呼吸疗法的缓解焦虑效果有待进一步研究,纳入的患者数量要更多,纳入标准要更严格。
{"title":"[Pilot study of breathing therapy in groups for patients with bronchial asthma].","authors":"Karoline von Steinaecker,&nbsp;Justus Welke,&nbsp;Malte Bühring,&nbsp;Rainer Stange","doi":"10.1159/000100378","DOIUrl":"https://doi.org/10.1159/000100378","url":null,"abstract":"<p><strong>Background: </strong>The present study examines the efficacy of breathing and body therapy (according to the organization of breathing therapists, BVA) on bronchial asthma. This psychophysical therapy procedure has never before been studied for its efficacy on asthma, much in contrast to breathing exercises, which have been extensively examined.</p><p><strong>Patients and methods: </strong>This uncontrolled observational study is of preliminary character. It examines the influence of psychophysical breathing and body exercises practiced in short-term intervention groups on quality of life (SF-36) as well as subjective discomfort (discomfort diary) in patients with bronchial asthma. As there are no prior studies on the breathing and body therapy (BVA) method, it was hypothesized, based on experience, that it would improve ventilation, lower anxiety, and perhaps even allow for a reduction of medication.</p><p><strong>Results: </strong>An anti-obstructive effect could not be addressed here, as the study only included patients who were free of clinically relevant obstructions through conventional treatment. However, a tendency for an anxiety-relieving effect could be observed in the SF-36. Subjective reports of respiratory discomfort, obtained through assessment of the patients' diaries, did not show any tendencies or even significant changes over the course of the therapy.</p><p><strong>Conclusion: </strong>The suggested anxiety-relieving effect of breathing therapy should be examined in future studies with more patients and stricter inclusion criteria.</p>","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 2","pages":"86-91"},"PeriodicalIF":0.0,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000100378","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26691179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Evidence based complementary and alternative medicine: promises and problems. 基于证据的补充和替代医学:承诺和问题。
Q Medicine Pub Date : 2007-04-01 Epub Date: 2007-04-23 DOI: 10.1159/000101054
Ian D Coulter

Objective: The present paper examines the experience of establishing a center for evidence-based complementary and alternative medicine (EBCAM) practice. It examines both the difficulties and the challenges of doing research to establish EBCAM. The paper also examines the political context of the demand for evidence- based practice (EBP) for CAM.

Implementation: A center for EBCAM was funded for 3 years within the Southern California Evidence-Based Practice Center by the National Center for CAM and administered by the Agency for Health Research Quality. This experience provides the basis for this paper.

Results: While the experience of creating an EBM Center for CAM has shown that much work can be accomplished by applying standard methods of EBP medicine, it also highlights the weaknesses of such an agenda. Many standard research methods are simply not applicable to CAM, and even where they are, effectiveness is a much more important means of assessing CAM than simply efficacy. Researchers however, must be conscious of the political motivations behind much of the demand for EBCAM. Where such demands are coming from allopathic medicine, they clearly form a continuing part of medical opposition to CAM and may be intended to perpetuate the dominance of the biomedical paradigm in healthcare. The challenge for CAM is to recognize the limitations of EBP but not to throw the 'baby out with the bathwater'. There is much in EBP that clearly should be emulated by the CAM community but only where it is appropriate.

目的:探讨建立循证补充替代医学(EBCAM)实践中心的经验。它考察了为建立EBCAM而进行研究的困难和挑战。本文还考察了CAM对基于证据的实践(EBP)需求的政治背景。实施情况:在南加州循证实践中心内,由国家循证实践中心资助了一个EBCAM中心,为期3年,由卫生研究质量局管理。这一经验为本文提供了依据。结果:虽然为CAM创建EBM中心的经验表明,通过应用EBP医学的标准方法可以完成许多工作,但它也突出了这样一个议程的弱点。许多标准的研究方法根本不适用于CAM,即使在适用的地方,有效性也是评估CAM的重要手段,而不仅仅是疗效。然而,研究人员必须意识到对EBCAM需求背后的政治动机。当这些需求来自对抗疗法医学时,它们显然形成了医学上反对辅助医学的持续部分,可能是为了使生物医学范式在医疗保健领域的主导地位永续下去。CAM面临的挑战是认识到EBP的局限性,而不是把“婴儿连同洗澡水一起倒掉”。在EBP中有很多东西显然应该被CAM社区模仿,但只在合适的地方。
{"title":"Evidence based complementary and alternative medicine: promises and problems.","authors":"Ian D Coulter","doi":"10.1159/000101054","DOIUrl":"https://doi.org/10.1159/000101054","url":null,"abstract":"<p><strong>Objective: </strong>The present paper examines the experience of establishing a center for evidence-based complementary and alternative medicine (EBCAM) practice. It examines both the difficulties and the challenges of doing research to establish EBCAM. The paper also examines the political context of the demand for evidence- based practice (EBP) for CAM.</p><p><strong>Implementation: </strong>A center for EBCAM was funded for 3 years within the Southern California Evidence-Based Practice Center by the National Center for CAM and administered by the Agency for Health Research Quality. This experience provides the basis for this paper.</p><p><strong>Results: </strong>While the experience of creating an EBM Center for CAM has shown that much work can be accomplished by applying standard methods of EBP medicine, it also highlights the weaknesses of such an agenda. Many standard research methods are simply not applicable to CAM, and even where they are, effectiveness is a much more important means of assessing CAM than simply efficacy. Researchers however, must be conscious of the political motivations behind much of the demand for EBCAM. Where such demands are coming from allopathic medicine, they clearly form a continuing part of medical opposition to CAM and may be intended to perpetuate the dominance of the biomedical paradigm in healthcare. The challenge for CAM is to recognize the limitations of EBP but not to throw the 'baby out with the bathwater'. There is much in EBP that clearly should be emulated by the CAM community but only where it is appropriate.</p>","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 2","pages":"102-8"},"PeriodicalIF":0.0,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000101054","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26691181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
[Replacing the hormone replacement therapy]. [替代激素替代疗法]。
Q Medicine Pub Date : 2007-04-01
Cornelia von Hagens
{"title":"[Replacing the hormone replacement therapy].","authors":"Cornelia von Hagens","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 2","pages":"116-7"},"PeriodicalIF":0.0,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26767217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[An old answer to an old question]. [老问题的老答案]。
Q Medicine Pub Date : 2007-04-01
Rainer Lüdtke
{"title":"[An old answer to an old question].","authors":"Rainer Lüdtke","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 2","pages":"114-5"},"PeriodicalIF":0.0,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26767215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts from the International Congress on Complementary Medicine Research, May 11-13, 2007, Munich, Germany. 国际补充医学研究大会,2007年5月11-13日,德国慕尼黑。
Q Medicine Pub Date : 2007-04-01 DOI: 10.1159/000101984
The quantity and quality of research in complementary therapies has increased dramatically over the last decade in parallel with the expertise and intellectual capacity available for evaluating this challenging field. While CAM research is highly heterogeneous, many of the questions and problems within CAM are similar and researchers in general benefit enormously from exchanging ideas. In 2000, the Centre for Complementary Medicine Research at the Technical University in Munich hosted a congress titled ‘Evidence-Based Complementary Medicine – State of the Evidence and Methodological Challenges’. This event was organized in collaboration with the Centre for Alternative Medicine Research and Education, Beth Israel Deaconess Medical Centre, Harvard Medical School. A total of 80 abstracts from 14 different countries were submitted for presentation, of which 65 were accepted [1]. Now in 2007, the Centre for Complementary Medicine Research and the International Society for Complementary Medicine Research (ISCMR) have jointly-organized the International Congress on Complementary Medicine Research which will be held Munich in May. ISCMR was established in 2003 to foster co-operative and multidisciplinary research and development within complementary, traditional and integrative medicine. We hope that ISCMR will build on its success and continue to be a major international forum for researchers in the field. These continuing conferences will be the forum through which leading Complementary and Alternative Medicine (CAM) researchers can present their new research and discuss future strategies. The conference organisers received a total of 264 abstracts from researchers in 26 different countries. In order to ensure scientific quality and to manage the Congress schedule, the Scientific Committee appointed a reviewing panel of 55 international expert volunteers. We are very grateful to them for their time, effort and expertise and would like to formally thank them for their work. Each abstract was evaluated by two external peer reviewers focussing on the criteria ‘relevance’, ‘clarity of methods’, ‘quality of writing style’ and ‘global assessment’. All the abstracts were also read by two of the conference organizers; only if the external peer reviewers disagreed were the actual scores used to decide upon the submission’s acceptance. Typical reasons for low scores were: prior publication of the submitted work, lack of clarity in the abstract, poor English, or a subject which might not be of interest to most Congress participants. We unfortunately had to reject 33% of the abstracts submitted, resulting in a scientific program of real excellence with 68 oral and 110 poster presentations. The variety of research topics submitted has increased dramatically when compared to the 2000 conference (see table). While in 2000 ‘miscellaneous topics’ comprised mainly methodological issues, these conferences’ abstracts now contain a number of new discrete disciplines such a
{"title":"Abstracts from the International Congress on Complementary Medicine Research, May 11-13, 2007, Munich, Germany.","authors":"","doi":"10.1159/000101984","DOIUrl":"https://doi.org/10.1159/000101984","url":null,"abstract":"The quantity and quality of research in complementary therapies has increased dramatically over the last decade in parallel with the expertise and intellectual capacity available for evaluating this challenging field. While CAM research is highly heterogeneous, many of the questions and problems within CAM are similar and researchers in general benefit enormously from exchanging ideas. In 2000, the Centre for Complementary Medicine Research at the Technical University in Munich hosted a congress titled ‘Evidence-Based Complementary Medicine – State of the Evidence and Methodological Challenges’. This event was organized in collaboration with the Centre for Alternative Medicine Research and Education, Beth Israel Deaconess Medical Centre, Harvard Medical School. A total of 80 abstracts from 14 different countries were submitted for presentation, of which 65 were accepted [1]. Now in 2007, the Centre for Complementary Medicine Research and the International Society for Complementary Medicine Research (ISCMR) have jointly-organized the International Congress on Complementary Medicine Research which will be held Munich in May. ISCMR was established in 2003 to foster co-operative and multidisciplinary research and development within complementary, traditional and integrative medicine. We hope that ISCMR will build on its success and continue to be a major international forum for researchers in the field. These continuing conferences will be the forum through which leading Complementary and Alternative Medicine (CAM) researchers can present their new research and discuss future strategies. The conference organisers received a total of 264 abstracts from researchers in 26 different countries. In order to ensure scientific quality and to manage the Congress schedule, the Scientific Committee appointed a reviewing panel of 55 international expert volunteers. We are very grateful to them for their time, effort and expertise and would like to formally thank them for their work. Each abstract was evaluated by two external peer reviewers focussing on the criteria ‘relevance’, ‘clarity of methods’, ‘quality of writing style’ and ‘global assessment’. All the abstracts were also read by two of the conference organizers; only if the external peer reviewers disagreed were the actual scores used to decide upon the submission’s acceptance. Typical reasons for low scores were: prior publication of the submitted work, lack of clarity in the abstract, poor English, or a subject which might not be of interest to most Congress participants. We unfortunately had to reject 33% of the abstracts submitted, resulting in a scientific program of real excellence with 68 oral and 110 poster presentations. The variety of research topics submitted has increased dramatically when compared to the 2000 conference (see table). While in 2000 ‘miscellaneous topics’ comprised mainly methodological issues, these conferences’ abstracts now contain a number of new discrete disciplines such a","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 Suppl 1 ","pages":"vii-viii, 1-53"},"PeriodicalIF":0.0,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000101984","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26797012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Prophylactic role for complementary and alternative medicine in perinatal programming of adult health. 补充和替代医学在成人保健围产期规划中的预防作用。
Q Medicine Pub Date : 2007-04-01 Epub Date: 2007-04-23 DOI: 10.1159/000100958
Deborah M Hodgson, Tamo Nakamura, Adam K Walker

Background: The health status of an individual in adulthood is proposed to be determined by events occurring in the prenatal and early postnatal period. A common early life event proven to have long lasting effects on the developing fetus is stress, including pain. Exposure of fetal and neonatal infants to repetitive psychological (e.g., maternal stress) or physiological (e.g., pain, infection, and noise) stress during this period is proposed to alter mechanisms involved in the regulation of stress, immunological maturation, pain perception, and cognition. Such changes, which persist into adulthood, may occur via alterations in the development of the hypothalamic-pituitary-adrenal (HPA) axis. This process is typically referred to as 'perinatal programming'. Ontogenic alterations in the development of the HPA-axis have been related to a number of adult pathologies such as cardiovascular disease, type 2 diabetes, asthma, as well as psychopathologies such as anxiety and depression.

Objective: In this review, the effectiveness of complementary and alternative medicine (CAM), such as music, dietary supplements, massage and aromatherapy, in reducing perinatal stress in mothers and infants is examined. An emphasis is placed on these therapies as preventative measures which may be of value to individuals at risk of developing disease profiles associated with the consequences of adverse perinatal programming. The widening interest in perinatal programming and CAM suggests the potential for CAM to become a valuable tool in offsetting negative adult health outcomes resulting from perinatal programming associated with adverse gestational early life environments.

背景:一个人成年后的健康状况被认为是由产前和产后早期发生的事件决定的。一个常见的早期生活事件被证明对发育中的胎儿有持久的影响,那就是压力,包括疼痛。在此期间,胎儿和新生儿暴露于重复的心理(如母亲压力)或生理(如疼痛、感染和噪音)压力下,可能会改变应激、免疫成熟、疼痛感知和认知的调节机制。这种持续到成年的变化可能是通过下丘脑-垂体-肾上腺(HPA)轴发育的改变而发生的。这一过程通常被称为“围产期规划”。hpa -轴发育过程中的个体发生改变与许多成人疾病有关,如心血管疾病、2型糖尿病、哮喘,以及焦虑和抑郁等精神病理。目的:本文综述了音乐、膳食补充剂、按摩和芳香疗法等辅助替代医学(CAM)在减轻母婴围产期压力方面的效果。重点放在这些治疗方法上,作为预防措施,对那些有可能因不良围产期规划的后果而罹患疾病的个人可能很有价值。围产期规划和CAM的日益广泛的兴趣表明,CAM有可能成为抵消与不良妊娠早期生活环境相关的围产期规划所造成的负面成人健康结果的有价值的工具。
{"title":"Prophylactic role for complementary and alternative medicine in perinatal programming of adult health.","authors":"Deborah M Hodgson,&nbsp;Tamo Nakamura,&nbsp;Adam K Walker","doi":"10.1159/000100958","DOIUrl":"https://doi.org/10.1159/000100958","url":null,"abstract":"<p><strong>Background: </strong>The health status of an individual in adulthood is proposed to be determined by events occurring in the prenatal and early postnatal period. A common early life event proven to have long lasting effects on the developing fetus is stress, including pain. Exposure of fetal and neonatal infants to repetitive psychological (e.g., maternal stress) or physiological (e.g., pain, infection, and noise) stress during this period is proposed to alter mechanisms involved in the regulation of stress, immunological maturation, pain perception, and cognition. Such changes, which persist into adulthood, may occur via alterations in the development of the hypothalamic-pituitary-adrenal (HPA) axis. This process is typically referred to as 'perinatal programming'. Ontogenic alterations in the development of the HPA-axis have been related to a number of adult pathologies such as cardiovascular disease, type 2 diabetes, asthma, as well as psychopathologies such as anxiety and depression.</p><p><strong>Objective: </strong>In this review, the effectiveness of complementary and alternative medicine (CAM), such as music, dietary supplements, massage and aromatherapy, in reducing perinatal stress in mothers and infants is examined. An emphasis is placed on these therapies as preventative measures which may be of value to individuals at risk of developing disease profiles associated with the consequences of adverse perinatal programming. The widening interest in perinatal programming and CAM suggests the potential for CAM to become a valuable tool in offsetting negative adult health outcomes resulting from perinatal programming associated with adverse gestational early life environments.</p>","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 2","pages":"92-101"},"PeriodicalIF":0.0,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000100958","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26691180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
[Japanese results are difficult to extrapolate to Europe]. (日本的结果很难推断到欧洲)。
Q Medicine Pub Date : 2007-04-01 DOI: 10.1159/000100962
Daniela Hacke
Foko_2006präs3.indd 2 07.12.2005 16:47:32 Liebe Leserinnen und Leser, gute Nachrichten sind schlechte Nachrichten, erzählen uns die Journalisten. Und berichten daher mit Vorliebe von Katastrophen, Morden und wirtschaftlichen Schieflagen statt von guten Taten. Bei Wissenschaftlern ist es ähnlich: Für sie sind negative Ergebnisse keine Ergebnisse, daher werden fast ausschließlich statistische Signifikanzen publiziert. Mit diesem Journal Club stellen wir uns dem Trend entgegen und widmen uns negativen Ergebnissen zur Komplementärmedizin. Und dieses aus gutem Grund: Negative Ergebnisse sind immer schwerer zu interpretieren als positive. Unterschiedliche Sichtweisen auf ein Thema können zu unterschiedlichen Schlussfolgerungen führen. Und so kommen im Folgenden unsere Kommentatoren auch nicht immer zum gleichen Schluss wie die Autoren. Rainer Lüdtke, Essen
{"title":"[Japanese results are difficult to extrapolate to Europe].","authors":"Daniela Hacke","doi":"10.1159/000100962","DOIUrl":"https://doi.org/10.1159/000100962","url":null,"abstract":"Foko_2006präs3.indd 2 07.12.2005 16:47:32 Liebe Leserinnen und Leser, gute Nachrichten sind schlechte Nachrichten, erzählen uns die Journalisten. Und berichten daher mit Vorliebe von Katastrophen, Morden und wirtschaftlichen Schieflagen statt von guten Taten. Bei Wissenschaftlern ist es ähnlich: Für sie sind negative Ergebnisse keine Ergebnisse, daher werden fast ausschließlich statistische Signifikanzen publiziert. Mit diesem Journal Club stellen wir uns dem Trend entgegen und widmen uns negativen Ergebnissen zur Komplementärmedizin. Und dieses aus gutem Grund: Negative Ergebnisse sind immer schwerer zu interpretieren als positive. Unterschiedliche Sichtweisen auf ein Thema können zu unterschiedlichen Schlussfolgerungen führen. Und so kommen im Folgenden unsere Kommentatoren auch nicht immer zum gleichen Schluss wie die Autoren. Rainer Lüdtke, Essen","PeriodicalId":54318,"journal":{"name":"Forschende Komplementarmedizin","volume":"14 2","pages":"111-2"},"PeriodicalIF":0.0,"publicationDate":"2007-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000100962","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26767212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Forschende Komplementarmedizin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1